These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 10625390)

  • 1. Resolution of cutaneous inflammation after local elimination of macrophages.
    Thepen T; van Vuuren AJ; Kiekens RC; Damen CA; Vooijs WC; van De Winkel JG
    Nat Biotechnol; 2000 Jan; 18(1):48-51. PubMed ID: 10625390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophages and cutaneous inflammation.
    McCormick TS; Stevens SR; Kang K
    Nat Biotechnol; 2000 Jan; 18(1):25-6. PubMed ID: 10625384
    [No Abstract]   [Full Text] [Related]  

  • 3. Selective elimination of synovial inflammatory macrophages in rheumatoid arthritis by an Fcgamma receptor I-directed immunotoxin.
    van Roon JA; van Vuuren AJ; Wijngaarden S; Jacobs KM; Bijlsma JW; Lafeber FP; Thepen T; van de Winkel JG
    Arthritis Rheum; 2003 May; 48(5):1229-38. PubMed ID: 12746896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant, ETA'-based CD64 immunotoxins: improved efficacy by increased valency, both in vitro and in vivo in a chronic cutaneous inflammation model in human CD64 transgenic mice.
    Ribbert T; Thepen T; Tur MK; Fischer R; Huhn M; Barth S
    Br J Dermatol; 2010 Aug; 163(2):279-86. PubMed ID: 20426788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD64-directed immunotoxin inhibits arthritis in a novel CD64 transgenic rat model.
    van Vuuren AJ; van Roon JA; Walraven V; Stuij I; Harmsen MC; McLaughlin PM; van de Winkel JG; Thepen T
    J Immunol; 2006 May; 176(10):5833-8. PubMed ID: 16670289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting CD64 mediates elimination of M1 but not M2 macrophages in vitro and in cutaneous inflammation in mice and patient biopsies.
    Hristodorov D; Mladenov R; von Felbert V; Huhn M; Fischer R; Barth S; Thepen T
    MAbs; 2015; 7(5):853-62. PubMed ID: 26218624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxicity of anti-CD64-ricin a chain immunotoxin against human acute myeloid leukemia cells in vitro and in SCID mice.
    Zhong RK; van de Winkel JG; Thepen T; Schultz LD; Ball ED
    J Hematother Stem Cell Res; 2001 Feb; 10(1):95-105. PubMed ID: 11276363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Fc receptors for IgG during acute and chronic cutaneous inflammation in atopic dermatitis.
    Kiekens RC; Thepen T; Bihari IC; Knol EF; Van De Winkel JG; Bruijnzeel-Koomen CA
    Br J Dermatol; 2000 Jun; 142(6):1106-13. PubMed ID: 10848732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depletion of synovial macrophages in rheumatoid arthritis by an anti-FcgammaRI-calicheamicin immunoconjugate.
    van Roon JA; Bijlsma JW; van de Winkel JG; Lafeber FP
    Ann Rheum Dis; 2005 Jun; 64(6):865-70. PubMed ID: 15539412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fully human MAP-fusion protein selectively targets and eliminates proliferating CD64(+) M1 macrophages.
    Hristodorov D; Mladenov R; Fischer R; Barth S; Thepen T
    Immunol Cell Biol; 2016 May; 94(5):470-8. PubMed ID: 26743033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. M2 macrophages phagocytose rituximab-opsonized leukemic targets more efficiently than m1 cells in vitro.
    Leidi M; Gotti E; Bologna L; Miranda E; Rimoldi M; Sica A; Roncalli M; Palumbo GA; Introna M; Golay J
    J Immunol; 2009 Apr; 182(7):4415-22. PubMed ID: 19299742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of IL-12 by topical corticosteroids in chronic atopic dermatitis.
    Yawalkar N; Karlen S; Egli F; Brand CU; Graber HU; Pichler WJ; Braathen LR
    J Allergy Clin Immunol; 2000 Nov; 106(5):941-7. PubMed ID: 11080718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCL27 is a critical factor for the development of atopic dermatitis in the keratin-14 IL-4 transgenic mouse model.
    Chen L; Lin SX; Agha-Majzoub R; Overbergh L; Mathieu C; Chan LS
    Int Immunol; 2006 Aug; 18(8):1233-42. PubMed ID: 16735375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of a potent and selective cytosolic phospholipase A2alpha inhibitor RSC-3388 on skin inflammation in mice.
    Yamamoto M; Haruna T; Imura K; Hikita I; Furue Y; Higashino K; Gahara Y; Deguchi M; Yasui K; Arimura A
    Pharmacology; 2008; 81(4):301-11. PubMed ID: 18287786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic engineering of an immunotoxin to eliminate pulmonary vascular leak in mice.
    Smallshaw JE; Ghetie V; Rizo J; Fulmer JR; Trahan LL; Ghetie MA; Vitetta ES
    Nat Biotechnol; 2003 Apr; 21(4):387-91. PubMed ID: 12627168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of CCR2 on monocytes and macrophages in chronically inflamed skin in atopic dermatitis and psoriasis.
    Vestergaard C; Just H; Baumgartner Nielsen J; Thestrup-Pedersen K; Deleuran M
    Acta Derm Venereol; 2004; 84(5):353-8. PubMed ID: 15370700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor alpha regulates skin inflammation and humoral response in atopic dermatitis.
    Staumont-Sallé D; Abboud G; Brénuchon C; Kanda A; Roumier T; Lavogiez C; Fleury S; Rémy P; Papin JP; Bertrand-Michel J; Tercé F; Staels B; Delaporte E; Capron M; Dombrowicz D
    J Allergy Clin Immunol; 2008 Apr; 121(4):962-8.e6. PubMed ID: 18249437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The anti-CD20 antibody rituximab augments the immunospecific therapeutic effectiveness of an anti-CD19 immunotoxin directed against human B-cell lymphoma.
    Flavell DJ; Warnes SL; Bryson CJ; Field SA; Noss AL; Packham G; Flavell SU
    Br J Haematol; 2006 Jul; 134(2):157-70. PubMed ID: 16771848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of TS-022, a newly developed prostanoid DP1 receptor agonist, on experimental pruritus, cutaneous barrier disruptions and atopic dermatitis in mice.
    Arai I; Takaoka A; Hashimoto Y; Honma Y; Koizumi C; Futaki N; Sugimoto M; Takahashi N; Inoue T; Nakanishi Y; Sakurai T; Tanami T; Yagi M; Ono N; Nakaike S
    Eur J Pharmacol; 2007 Feb; 556(1-3):207-14. PubMed ID: 17141215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapeutic strategies in neuroblastoma: antitumoral activity of deglycosylated Ricin A conjugated anti-GD2 antibodies and anti-CD3xanti-GD2 bispecific antibodies.
    Manzke O; Russello O; Leenen C; Diehl V; Bohlen H; Berthold F
    Med Pediatr Oncol; 2001 Jan; 36(1):185-9. PubMed ID: 11464879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.